Pfizer (PFE)

Cost of Revenue

$18.27B

TTM · Period ending: · USD

PFE logo

PFE Cost of Revenue

Latest reported$18.27B
PFE TTM Cost of Revenue ($0.00 → $18.27B)
High-resolution chart · PNG

PFE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
4,778,000,000
4,457,000,000
3,576,000,000
2,901,000,000
2,379,000,000
1,910,000,000
1,985,000,000
2,098,000,000
1,724,000,000
1,816,000,000
1,809,000,000
1,704,000,000
1,824,000,000
1,752,000,000
1,772,000,000
1,728,000,000
1,730,000,000
1,765,000,000
1,746,000,000
1,706,600,000
1,762,200,000
1,860,000,000
1,883,900,000
1,892,200,000
1,821,400,000
1,703,000,000
1,628,200,000
1,568,400,000
1,536,300,000
1,515,900,000
1,516,100,000
1,565,600,000
1,648,000,000
1,703,900,000
1,762,900,000
1,858,700,000
1,886,300,000
1,912,900,000
1,956,500,000
2,001,000,000
2,034,200,000
2,053,900,000
2,034,000,000
1,436,100,000
920,200,000
444,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.